The advantage of [18F]ML-10, compared to other radiotracers targeting apoptosis (radiolabeled Annexin V and radiolabeled Caspase-3), is a rapid biodistribution due to its low molecular weight and hydrophilicity which allows early tumor imaging including brain cancer. This evidence concerns the gene ANXA5 and brain cancer.